Cargando...
The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage
BACKGROUND AND PURPOSE: It has been shown that 3 days of 62 mg/kg/day deferoxamine infusion (maximum dose not to exceed 6000 mg/day) is safe and tolerated by intracerebral hemorrhage (ICH) patients. The aim of this study was to investigate the efficacy of deferoxamine mesylate for edema resolution a...
Guardado en:
| Publicado en: | PLoS One |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4395224/ https://ncbi.nlm.nih.gov/pubmed/25875777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0122371 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|